Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,200
Closed -$227K 12671
2024
Q2
$227K Buy
+5,200
New +$251K ﹤0.01% 10068
2023
Q4
Sell
-5,200
Closed -$248K 12976
2023
Q3
$248K Sell
5,200
-7,400
-59% -$404K ﹤0.01% 9771
2023
Q2
$733K Buy
12,600
+2,000
+19% +$120K ﹤0.01% 7410
2023
Q1
$758K Buy
10,600
+3,700
+54% +$294K ﹤0.01% 7526
2022
Q4
$486K Buy
6,900
+2,400
+53% +$169K ﹤0.01% 7936
2022
Q3
$273K Buy
+4,500
New +$302K ﹤0.01% 10037
2022
Q1
Sell
-3,900
Closed -$280K 13646
2021
Q4
$280K Sell
3,900
-13,200
-77% -$1M ﹤0.01% 10650
2021
Q3
$1.22M Buy
17,100
+6,700
+64% +$528K ﹤0.01% 7034
2021
Q2
$846K Sell
10,400
-2,000
-16% -$161K ﹤0.01% 8217
2021
Q1
$937K Sell
12,400
-1,700
-12% -$124K ﹤0.01% 7914
2020
Q4
$1.07M Buy
14,100
+9,000
+176% +$586K ﹤0.01% 6577
2020
Q3
$252K Sell
5,100
-12,500
-71% -$705K ﹤0.01% 9054
2020
Q2
$925K Sell
17,600
-5,900
-25% -$280K ﹤0.01% 6103
2020
Q1
$827K Buy
23,500
+15,200
+183% +$888K ﹤0.01% 5816
2019
Q4
$725K Sell
8,300
-3,200
-28% -$280K ﹤0.01% 6190
2019
Q3
$976K Buy
11,500
+8,700
+311% +$775K ﹤0.01% 5745
2019
Q2
$294K Sell
2,800
-2,700
-49% -$271K ﹤0.01% 8359
2019
Q1
$581K Buy
5,500
+2,400
+77% +$241K ﹤0.01% 5998
2018
Q4
$259K Buy
3,100
+400
+15% +$36.2K ﹤0.01% 7269
2018
Q3
$275K Buy
+2,700
New +$261K ﹤0.01% 7646
2017
Q4
Sell
-12,300
Closed -$768K 9690
2017
Q3
$768K Sell
12,300
-1,200
-9% -$71.1K ﹤0.01% 5756
2017
Q2
$775K Buy
13,500
+7,400
+121% +$435K ﹤0.01% 5801
2017
Q1
$371K Buy
6,100
+1,700
+39% +$96.2K ﹤0.01% 7018
2016
Q4
$241K Sell
4,400
-200
-4% -$9.59K ﹤0.01% 8360
2016
Q3
$212K Buy
+4,600
New +$194K ﹤0.01% 7500

Other funds holding NGVT

Jeff Yass's NGVT Position: Q2 2026 in Review

Jeff Yass reduced its Ingevity (NGVT) stake by 74% in Q2 2026, selling an estimated $3.08M and leaving 14,879 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #7930.

Jeff Yass first reported a position in NGVT in Q4 2016 and has held it in 33 quarters since. The position peaked at $30.1M in Q1 2019. 313 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Jeff Yass held 14,879 shares of Ingevity worth $1.11M as of Q2 2026.
  • Jeff Yass sold 42,731 Ingevity shares in Q2 2026, an estimated $3.08M.
  • Ingevity made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7930 holding.
  • Jeff Yass first reported a position in Ingevity in Q4 2016 and has held it in 33 quarters since.
  • Jeff Yass's Ingevity position peaked at $30.1M in Q1 2019.
  • 313 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.